Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition von Corey, Lawrence, Gilbert, Peter B, Juraska, Michal, Montefiori, David C, Morris, Lynn, Karuna, Shelly T, Edupuganti, Srilatha, Mgodi, Nyaradzo M, deCamp, Allan C, Rudnicki, Erika, Huang, Yunda, Gonzales, Pedro, Cabello, Robinson, Orrell, Catherine, Lama, Javier R, Laher, Fatima, Lazarus, Erica M, Sanchez, Jorge, Frank, Ian, Hinojosa, Juan, Sobieszczyk, Magdalena E, Marshall, Kyle E, Mukwekwerere, Pamela G, Makhema, Joseph, Baden, Lindsey R, Mullins, James I, Williamson, Carolyn, Hural, John, McElrath, M. Juliana, Bentley, Carter, Takuva, Simbarashe, Gomez Lorenzo, Margarita M, Burns, David N, Espy, Nicole, Randhawa, April K, Kochar, Nidhi, Piwowar-Manning, Estelle, Donnell, Deborah J, Sista, Nirupama, Andrew, Philip, Kublin, James G, Gray, Glenda, Ledgerwood, Julie E, Mascola, John R, Cohen, Myron S

Volltext

Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084 von Moretlwe, S. Delany, Hughes, J, Bock, P, Gurrion, S, Hunidzarira, P, Kalonji, D, Kayange, N, Makhema, J, Mandima, P, Mathew, C, Mokgoro, M, Mpendo, J, Mukwekwerere, P, Mgodi, N, Ntege, P. Nahirya, Nair, G, Nakabiito, C, Biribonwoha, H. Nuwagaba, Panchia, R, Singh, N

Volltext

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial von Fichtenbaum, Carl J, Ribaudo, Heather J, Leon-Cruz, Jorge, Overton, Edgar T, Zanni, Markella V, Malvestutto, Carlos D, Aberg, Judith A, Kileel, Emma M, Fitch, Kathleen V, Van Schalkwyk, Marije, Kumarasamy, Nagalingeswaran, Martinez, Esteban, Santos, Breno Riegel, Joseph, Yvetot, Lo, Janet, Siminski, Sue, Melbourne, Kathleen, Sponseller, Craig A, Desvigne-Nickens, Patrice, Bloomfield, Gerald S, Currier, Judith S, Hoffmann, Udo, Douglas, Pamela S, Grinspoon, Steven K

Volltext